Dynamic Trends and Practice Patterns in Femoropopliteal Revascularization From 2016 Through 2023.

COI Statement

Funding Support and Author Disclosures This research was sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) and supported by an educational grant from Abbott Vascular. The views presented here represent those of the authors and do not necessarily reflect the official views of SCAI or Abott Vascular. Dr Yeh has received research funding from Boston Scientific, Abbott, and Medtronic; and has been a consultant for Boston Scientific, Abbott, Medtronic, Edwards, CathWorks, and Shockwave. Dr Secemsky has received research funding from NIH/NHLBI K23HL150290, U.S. Food and Drug Administration, SCAI, Abbott/CSI, BD, Boston Scientific, Cook, Medtronic, and Philips; and has been a consultant for Abbott/CSI, BD, Bristol Myers Squibb, Boston Scientific, Cagent, Conavi, Cook, Cordis, Endovascular Engineering, Gore, InfraRedx, Medtronic, Philips, RapidAI, Rampart, Shockwave, Terumo, Thrombolex, VentureMed, and Zoll. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.